- Sep 29, 2004
- 18,656
- 67
- 91
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Originally posted by: dmcowen674
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Of course, Profits over human life.
Originally posted by: Hafen
Originally posted by: dmcowen674
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Of course, Profits over human life.
You are right Dave, this is a win for human health care and life over the profits of trial lawyers. Pharma money is best spent on researching new medicines and saving laves rather than lining the pockets of shady lawyers. :thumbsup:
Originally posted by: dahunan
Originally posted by: Hafen
Originally posted by: dmcowen674
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Of course, Profits over human life.
You are right Dave, this is a win for human health care and life over the profits of trial lawyers. Pharma money is best spent on researching new medicines and saving laves rather than lining the pockets of shady lawyers. :thumbsup:
So, you are saying that Big Pharma is less CORRUPT than a Trial Lawyer? If you truly think they are then by how much would you say they are.. 5%, 10%?
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Merck has now won one out of two of the suits that have gone to trial, but they have thousands more to go. As an American citizen who demands more from the FDA than a sell out to big Pharma, NO! :thumbsdown: :|Originally posted by: IHateMyJob2004
As a share holder, YES!
From CNN:Health & Science
Report Finds Merck Hid Vioxx Concerns
All Things Considered, November 1, 2004
According to the Wall Street Journal, pharmaceutical company Merck fought to conceal safety concerns for several years before withdrawing the painkiller Vioxx from the market in September. Hear Journal reporter Barbara Martinez, who coauthored the report.
Part 1: Documents Suggest Merck Tried to Censor Vioxx Critics
by Snigdha Prakash
All Things Considered, June 9, 2005
Introduction: At least 38,000 Americans are believed to have died from taking the pain pill Vioxx before it was withdrawn last year. Drug maker Merck is now facing thousands of lawsuits.
Over the past few months, it has emerged that the company was aware for years that Vioxx might be dangerous. Now, new documents obtained by NPR suggest that even as Merck was making Vioxx into a bestseller, the company was putting pressure on independent doctors. The company's apparent aim: to keep them from discussing evidence of Vioxx's potential safety problems. The documents show that Merck exerted pressure not only on individual doctors, but also on several of the nation's top medical schools. (Part 1 continues)
Part 2: Did Merck Try to Censor Vioxx Critics?
by Snigdha Prakash
All Things Considered, June 9, 2005
Introduction: NPR's story about Merck and its efforts to suppress safety concerns about the painkiller Vioxx continues with a look at how Merck exerted its influence in the world of top medical institutions.
Dr. Louis Sherwood's campaign to "fix" Vioxx critic Gurkirpal Singh began with a series of phone calls to Singh's bosses at Stanford University.
"I don't usually receive phone calls on a Saturday at home from representatives of drug companies," says James Fries, a professor of medicine at Stanford. "So it was definitely unusual."
The call came on Oct. 28, 2000. " I received a call from a medical director at Merck, stating that someone on my staff had been making wild and irresponsible public statements about the cardiovascular side effects of Vioxx," Fries says. He says Sherwood hinted there would be repercussions for Fries and Stanford if Singh's statements didn't stop. He was left with the sense that Merck's financial support to Stanford was at risk. (Part 2 continues)
Medical Schools and Drug Firm Dollars
by Joe Neel
NPR.org, June 9, 2005
An informal survey of medical schools by NPR found that some schools rely on funding from pharmaceutical and other health-industry sources.
The issue is taking on increasing importance. Government funding for medical research is not expected to increase in coming years and could decline. Medical schools will be more reliant on private, for-profit industry for funding. That raises concerns about academic freedom and restrictions on what researchers can and cannot say in print and in public. (story continues)
Merck Attempted to Quash Vioxx Criticism
by Snigdha Prakash
Morning Edition, June 10, 2005
Drug maker Merck attempted to censor critics of Vioxx as early as 2000, an investigation by NPR finds. That year, a study indicated that the painkiller might cause heart problems. The story raises larger issues about the role of pharmaceutical firms' funding of medical schools and independent doctors. (story continues)
Merck Attempted to Quash Vioxx Criticism
Merck's Vioxx e-mail scrutinized
Report: Letters show company executives long aware of links between pain drug and heart risks.
November 1, 2004: 6:55 AM EST
NEW YORK (CNN/Money) - Internal Merck & Co. e-mails and marketing materials show the drugmaker fought forcefully for years to keep safety concerns from destroying the sales of big-selling painkiller Vioxx, according to a published report.
The Wall Street Journal reported Monday that the e-mails seen by the paper show that Merck executives were worried in the mid-to-late 1990's that Vioxx would show greater heart risk than cheaper painkillers that were harsh on the stomach but were believed to reduce the risk of heart attacks. The company pulled Vioxx off the market in September, citing increased cardiac risk.
The paper said that several company officials discussed in e-mails how to design a study that would minimize the finding that Vioxx had a higher heart attack risk than the cheaper drugs, even though some of those writing the e-mails believed that damaging comparisons would be difficult to conceal.
The paper reported that, in a March 9, 2000 e-mail, Merck research chief Edward Scolnick stated the cardiovascular events "are clearly there" and called it a "shame." The paper said he compared Vioxx to other drugs with known side effects and wrote, "there is always a hazard."
Merck continued to deny any link between heart attacks and Vioxx up until the announcement that the drug was being pulled from the market.
Merck faces lawsuits by those who suffered heart attacks after taking the drug, as well as from family members. The e-mails and documents reviewed by the Journal could hurt the company in those suits.
A lawyer representing Merck told the Journal the internal e-mails and marketing materials were "taken out of context" and "do not accurately represent the conduct of Merck and its employees." But the paper said the company did not provide additional material to place the damaging e-mails in context, citing the pending litigation.
Shares of Merck (Research), a component of the Dow Jones industrial average, lost more than 1 percent in trading in Frankfurt following the early-morning report.
Originally posted by: Hafen
Even the day of the Vioxx withdrawl I heard ads on the radio: "Have you taken Vioxx? It has been shown to cause heart attacks and death. If you have taken even a single dose you may be entitled to monetary damages. Please call the law offices of Dewey, Cheetum and Howe NOW! A consultaion costs you nothing. We don't get paid unless you do!" :thumbsdown:
Originally posted by: zendari
Originally posted by: Hafen
Even the day of the Vioxx withdrawl I heard ads on the radio: "Have you taken Vioxx? It has been shown to cause heart attacks and death. If you have taken even a single dose you may be entitled to monetary damages. Please call the law offices of Dewey, Cheetum and Howe NOW! A consultaion costs you nothing. We don't get paid unless you do!" :thumbsdown:
Specifically on this last point, is the man who sued Merck liable for all of their legal costs? They would have spent hundreds of thousands on this man's bogus claims.
Originally posted by: Hafen
Originally posted by: dmcowen674
Originally posted by: IHateMyJob2004
http://biz.yahoo.com/ap/051103/vioxx_litigation.html?.v=27
As a share holder, YES!
Of course, Profits over human life.
You are right Dave, this is a win for human health care and life over the profits of trial lawyers. Pharma money is best spent on researching new medicines and saving laves rather than lining the pockets of shady lawyers. :thumbsup: